Static Chart CRISPR Therapeutics AG

Equities

Real-time Estimate Cboe BZX Other stock markets 01:07:42 2024-05-13 pm EDT			5-day change	1st Jan Change
54.94 ^USD	+7.37%		-3.05%	-11.63%

May. 10	Oppenheimer Adjusts CRISPR Therapeutics Price Target to $95 From $102, Maintains Outperform Rating	MT
May. 09	Barclays Adjusts Price Target on CRISPR Therapeutics to $67 From $80, Maintains Equal-Weight Rating	MT

Duration

Period